ALMKT:EPA
Mauna Kea Technologies SA
0,14 €
arrow_downward
-0,71%(-0,0010) 1D
30-сен., 17:35:19 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
0,14 €
High
0,14 €
Low
0,13 €
Mkt. cap
27,57 млн
Avg. vol.
427,19 миң
Volume
632,73 миң
P/E ratio
1,15
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 млн
No. of employees
59
Open
0,14 €
High
0,14 €
Low
0,13 €
Mkt. cap
27,57 млн
Avg. vol.
427,19 миң
Volume
632,73 миң
P/E ratio
1,15
52-wk high
0,23 €
52-wk low
0,07 €
EPS
0,12 €
Shares outstanding
195,26 млн
No. of employees
59
News stories
From web sources and news partners
Simply Wall Street
·
29 мүнөт мурун
Learn Why The Bull Case For Amplitude (AMPL) Could Change Following Earnings Beat
ABC4 Utah
·
1 саат мурун
Asian shares mostly rise amid market optimism about AI, despite Iran worries
marketscreener.com
·
1 саат мурун
S&P 500 index retreated after the Stockholm exchange closed on Wednesday
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA